Studies have shown GD3S inhibitors, such as Triptolide (TPL) from Tripterygium wilfordii, have anti-rheumatic, anti-inflammatory, immunomodulatory, and anti-tumor properties. This evidence concerns the gene ST8SIA1 and neoplasm.